Cargando…

Quantitative Cross-Sectional Study About the Prevalence of Depression Among Epileptic Patients in Saudi Arabia

Background: There are high prevalence of mental health co-morbidities in people with epilepsy, with major depressive disorder being the most common among them. Objective: This study aims to investigate the prevalence of depression among epileptic patients in Saudi Arabia. We also explored some of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Albalawi, Reema Saleh A, Alanzi, Sarah Mutlq O, Alharthe, Amjad Fiusal H, Atawi, Sarah Hadi S, Albalawi, Rahaf Masoud D, Alanazi, Hind Abdulaziz S, Alsayed, Maram Saleh A, Zubair, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584377/
https://www.ncbi.nlm.nih.gov/pubmed/37859888
http://dx.doi.org/10.7759/cureus.45491
Descripción
Sumario:Background: There are high prevalence of mental health co-morbidities in people with epilepsy, with major depressive disorder being the most common among them. Objective: This study aims to investigate the prevalence of depression among epileptic patients in Saudi Arabia. We also explored some of the sociodemographic and clinical variables associated with depression in epilepsy. Methods: This was a cross-sectional analysis executed across the four geographical regions of Saudi Arabia and the sample size is calculated to be 358. Data collection was facilitated through a digital self-administered questionnaire, which consisted of three parts: patients' sociodemographic variables, clinical variables, and patient health questionnaire (PHQ-9) depression score. Data processing and analytical procedures are undertaken using the SPSS software. Results: Of the participants, 311 responded: 65.6% were females, and 34.4% were males. Approximately 50.5% had a confirmed epilepsy diagnosis and were included in the PHQ-9 depression score analysis. Notably, 84.7% manifested depressive symptoms, with the severe category being predominant at 84.7% and moderate at 3.8%. An intriguing observation was the heightened prevalence among the younger demographic (16 to 24 years), registering at 34.4%, a figure nearly 3% superior to older age brackets. Conclusion: The majority of participants manifested depressive symptoms, with a significant association noted between medication quantity and depression prevalence in epilepsy. It is imperative to broaden the scope of research, encompassing varied methodologies and spanning multiple urban centers, to procure more robust and generalizable conclusions.